Artículos por temáticas

Shared mechanisms: osteoporosis and Alzheimer's disease?

Dengler-Crish CM, Elefteriou F.

Aging (Albany NY). 2019 Feb 19;11(5):1317-1318. doi: 10.18632/aging.101828.

Screaming behaviour in response to electroconvulsive treatment: psychogeriatric note on a patient with Alzheimer's disease

Johari N, Glue P, Barak Y.

Psychogeriatrics. 2019 Nov;19(6):626-627. doi: 10.1111/psyg.12443. Epub 2019 Mar 5.

Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease

Wright JW, Harding JW.

J Alzheimers Dis. 2019;67(2):469-480. doi: 10.3233/JAD-181035.

Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine

Zeng Q, Siu W, Li L, Jin Y, Liang S, Cao M, Ma M, Wu Z.

Exp Gerontol. 2019 May;119:100-110. doi: 10.1016/j.exger.2019.01.027. Epub 2019 Jan 30.

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets

Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E.

Br J Pharmacol. 2019 Sep;176(18):3515-3532. doi: 10.1111/bph.14618. Epub 2019 May 11.

Stress and Alzheimer's disease

Escher CM, Sannemann L, Jessen F.

J Neural Transm (Vienna). 2019 Sep;126(9):1155-1161. doi: 10.1007/s00702-019-01988-z. Epub 2019 Feb 20.

Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease

Huang YM, Shen J, Zhao HL.

J Am Geriatr Soc. 2019 Apr;67(4):841-844. doi: 10.1111/jgs.15830. Epub 2019 Mar 9.

Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case- Control Studies

Brown EE, Shah P, Pollock BG, Gerretsen P, Graff-Guerrero A.

Curr Alzheimer Res. 2019;16(4):353-361. doi: 10.2174/1567205016666190311101445.

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L, Voyle N, Proitsi P, Witoelar A, Stringer S, Aarsland D, Almdahl IS, Andersen F, Bergh

Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease

Rubin LH, Sundermann EE, Moore DJ.

J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22.

The Potential Role of Dysregulated miRNAs in Alzheimer's Disease Pathogenesis and Progression

Patel AA, Ganepola GAP, Rutledge JR, Chang DH.

J Alzheimers Dis. 2019;67(4):1123-1145. doi: 10.3233/JAD-181078.

Neuroinflammation and fractalkine signaling in Alzheimer's disease

Finneran DJ, Nash KR.

J Neuroinflammation. 2019 Feb 11;16(1):30. doi: 10.1186/s12974-019-1412-9.

Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity

Mullane K, Williams M.

Curr Protoc Pharmacol. 2019 Mar;84(1):e57. doi: 10.1002/cpph.57. Epub 2019 Feb 25.

Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysis

Gatt A, Lee H, Williams G, Thuret S, Ballard C.

Neurobiol Aging. 2019 Apr;76:166-180. doi: 10.1016/j.neurobiolaging.2018.12.016. Epub 2019 Jan 8.

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred

Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reim

J Prev Alzheimers Dis. 2019;6(2):112-120. doi: 10.14283/jpad.2019.6.